Portman Square Capital’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,842,400
Closed -$20.4M 272
2024
Q3
$20.4M Buy
2,842,400
+379,300
+15% +$3.49M 0.76% 29
2024
Q2
$25.6M Sell
2,463,100
-173,900
-7% -$1.74M 0.88% 20
2024
Q1
$26.5M Buy
2,637,000
+861,200
+48% +$9.26M 0.73% 36
2023
Q4
$27.1M Hold
1,775,800
0.62% 41
2023
Q3
$24.8M Buy
+1,775,800
New +$26.9M 0.61% 40
2023
Q2
Sell
-1,166,900
Closed -$18.8M 419
2023
Q1
$18.8M Sell
1,166,900
-591,300
-34% -$10.5M 0.86% 29
2022
Q4
$26.2M Buy
+1,758,200
New +$30.6M 1.93% 9

Other funds holding HLF

Portman Square Capital's HLF Position: Q4 2024 in Review

Portman Square Capital sold out of Herbalife (HLF) in Q4 2024, closing a stake of 10,186 shares — an estimated $73.2K sold.

Portman Square Capital first reported a position in HLF in Q4 2022 and held it in 7 quarters. The position peaked at $3.5M in Q3 2023. 199 funds tracked by Wall St. Rank hold HLF as of Q4 2024.

  • Portman Square Capital reported no remaining Herbalife position as of Q4 2024 after selling out during the quarter.
  • Portman Square Capital sold 10,186 Herbalife shares in Q4 2024, an estimated $73.2K.
  • Portman Square Capital first reported a position in Herbalife in Q4 2022 and held it in 7 quarters.
  • Portman Square Capital's Herbalife position peaked at $3.5M in Q3 2023.
  • 199 funds tracked by Wall St. Rank held Herbalife as of Q4 2024.

Based on Portman Square Capital's 13F filing for Q4 2024, filed 16 Jan 2025.